These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 3247588)
1. Assessment of gastric antisecretory effects of phenoxyisobutyrate derivatives in the rat and the mouse. Eason CT; Pattison A; Howells DD; Spencer AJ; Bonner FW Scand J Gastroenterol; 1988 Nov; 23(9):1063-71. PubMed ID: 3247588 [TBL] [Abstract][Full Text] [Related]
2. Gastric morphological changes including carcinoid tumors in animals treated with a potent hypolipidemic agent, ciprofibrate. Spencer AJ; Barbolt TA; Henry DC; Eason CT; Sauerschell RJ; Bonner FW Toxicol Pathol; 1989; 17(1 Pt 1):7-15. PubMed ID: 2501865 [TBL] [Abstract][Full Text] [Related]
3. The effect of ciprofibrate on gastric secretion in the rat. Eason CT; Pattison A; Howells DD; Bonner FW J Pharm Pharmacol; 1988 Jul; 40(7):512-3. PubMed ID: 2904995 [TBL] [Abstract][Full Text] [Related]
4. Species variation in gastric toxicity following chronic administration of ciprofibrate to rat, mouse, and marmoset. Eason CT; Spencer AJ; Pattison A; Howells DD; Henry DC; Bonner FW Toxicol Appl Pharmacol; 1988 Sep; 95(2):328-38. PubMed ID: 3138789 [TBL] [Abstract][Full Text] [Related]
5. The comparative pharmacokinetics and gastric toxicity of bezafibrate and ciprofibrate in the rat. Eason CT; Powles P; Henry G; Spencer AJ; Pattison A; Bonner FW Xenobiotica; 1989 Aug; 19(8):913-25. PubMed ID: 2815833 [TBL] [Abstract][Full Text] [Related]
7. Effects of treatment with clofibrate, bezafibrate, and ciprofibrate on the metabolism of cholesterol in rat liver microsomes. Ståhlberg D; Angelin B; Einarsson K J Lipid Res; 1989 Jul; 30(7):953-8. PubMed ID: 2794793 [TBL] [Abstract][Full Text] [Related]
8. Gemfibrozil increases both apo A-I and apo E concentrations. Comparison to other lipid regulators in cholesterol-fed rats. Krause BR; Newton RS Atherosclerosis; 1986 Jan; 59(1):95-8. PubMed ID: 3081014 [TBL] [Abstract][Full Text] [Related]
9. Fatty acid metabolism in hepatocytes cultured with hypolipidaemic drugs. Role of carnitine. Gerondaes P; Alberti KG; Agius L Biochem J; 1988 Jul; 253(1):161-7. PubMed ID: 3048253 [TBL] [Abstract][Full Text] [Related]
10. Irreversible inhibition of hepatic glutathione S-transferase by ciprofibrate, a peroxisome proliferator. Awasthi YC; Singh SV; Goel SK; Reddy JK Biochem Biophys Res Commun; 1984 Sep; 123(3):1012-8. PubMed ID: 6487318 [TBL] [Abstract][Full Text] [Related]
11. Effect of ciprofibrate, bezafibrate, and LY171883 on peroxisomal beta-oxidation in cultured rat, dog, and rhesus monkey hepatocytes. Foxworthy PS; White SL; Hoover DM; Eacho PI Toxicol Appl Pharmacol; 1990 Jul; 104(3):386-94. PubMed ID: 1974728 [TBL] [Abstract][Full Text] [Related]
12. Fibrates induce mdr2 gene expression and biliary phospholipid secretion in the mouse. Chianale J; Vollrath V; Wielandt AM; Amigo L; Rigotti A; Nervi F; Gonzalez S; Andrade L; Pizarro M; Accatino L Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):781-6. PubMed ID: 8615769 [TBL] [Abstract][Full Text] [Related]
13. Interactions of inhibitors of carnitine palmitoyltransferase I and fibrates in cultured hepatocytes. Gerondaes P; Alberti KG; Agius L Biochem J; 1988 Jul; 253(1):169-73. PubMed ID: 3421940 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the hepatic responses to the short-term administration of ciprofibrate in several rat strain. Co-induction of microsomal cytochrome P-450 IVA1 and peroxisome proliferation. Makowska JM; Anders C; Goldfarb PS; Bonner F; Gibson GG Biochem Pharmacol; 1990 Sep; 40(5):1083-93. PubMed ID: 2390105 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of liver cell proliferation during ciprofibrate-induced hepatocarcinogenesis. Yeldandi AV; Milano M; Subbarao V; Reddy JK; Rao MS Cancer Lett; 1989 Sep; 47(1-2):21-7. PubMed ID: 2636030 [TBL] [Abstract][Full Text] [Related]
16. Effect of fibric acid derivatives on blood lipid and lipoprotein levels. Hunninghake DB; Peters JR Am J Med; 1987 Nov; 83(5B):44-9. PubMed ID: 3318453 [TBL] [Abstract][Full Text] [Related]
17. Induction of peroxisome proliferation and hepatic tumours in C57BL/6N mice by ciprofibrate, a hypolipidaemic compound. Rao MS; Dwivedi RS; Subbarao V; Reddy JK Br J Cancer; 1988 Jul; 58(1):46-51. PubMed ID: 2901849 [TBL] [Abstract][Full Text] [Related]
18. Effects of ciprofibrate and 2-[5-(4-chlorophenyl)pentyl]oxirane-2-carboxylate (POCA) on the distribution of carnitine and CoA and their acyl-esters and on enzyme activities in rats. Relation between hepatic carnitine concentration and carnitine acetyltransferase activity. Bhuiyan AK; Bartlett K; Sherratt HS; Agius L Biochem J; 1988 Jul; 253(2):337-43. PubMed ID: 3178716 [TBL] [Abstract][Full Text] [Related]
19. Effects of clofibric acid and bezafibrate administration on activities of alkaline phosphatase and other enzymes in livers of rats. Walli AK; Seidel D Res Exp Med (Berl); 1981; 179(2):153-61. PubMed ID: 7280363 [TBL] [Abstract][Full Text] [Related]
20. Single and chronic administration of ciprofibrate or of ciprofibrate-glycinate in male Fischer 344 rats: comparison of the effects on morphological and biochemical parameters in liver and blood. Lupp A; Karge E; Danz M; Deufel T; Oelschläger H; Klinger W Eur J Drug Metab Pharmacokinet; 2005; 30(3):203-18. PubMed ID: 16250258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]